Investigational Site Number :1560022

Changsha 410013

0 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Diseases, Chronic Obstructive Pulmonary Disease, Heart Failure, Type 2 Diabetes Mellitus

Studies at this site

• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation — Completed
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early